Floatz logo

Equine Atg

Acute Lymphoblastic Leukemia

Instituto Nacional de Cancer, BrazilUNKNOWNPhase 3Active
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
60/ 100
Competitive Position
95/ 100

Competitive context

246 Active assets in the Acute Lymphoblastic Leukemia cohort.

Asset / SponsorPhaseRating
Peripheral Blood Stem Cells, Allogeneic, Cd34 Positive
Fred Hutchinson Cancer Center
Phase 2/3BBB
Gm-Csf
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase 4BBB
THIOGUANINE ANHYDROUS
St. Jude Children's Research Hospital
Phase 4BBB
Vincristine sulfate
Children's Oncology Group
Phase 3BB
MERCAPTOPURINE ANHYDROUS
Dana-Farber Cancer Institute
Phase 4BB

View all 50 →

Same molecule, other indications

Equine Atg is also rated in:

disease related to hematopoietic stem cell transplantActive
BB
Indicative · Phase 3
68 / 100
View asset →
myelodysplastic syndromeActive
BB
Indicative · Phase 3
66 / 100
View asset →
disease related to solid organ transplantationDormant
BB
Indicative · Phase 4
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →